RonaldSGoMD

PubMed

• 523 citations
  Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxo...
  Tina Green, Ken H. Young, Carlo Visco, Zijun Y. Xu-Monette, Attilio Orazi
  Journal of Clinical Oncology. 2012-06-04
• 60 citations
  Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
  Nadine Abdallah, S. Vincent Rajkumar, Patricia T. Greipp, Prashant Kapoor, Morie A. Gertz
  Blood Cancer Journal. 2020-08-11
• 82 citations
  Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category.
  Eli Muchtar, Angela Dispenzieri, Shaji Kumar, Rhett P. Ketterling, David Dingli
  Leukemia. 2017-07-01

Journal Articles

• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
• Join now to see all

Abstracts/Posters

• Molecular Alterations in Adult Histiocytic Neoplasms
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study
  Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Association between Treatment Facility Volume and Mortality of Patients with Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long-Term Survivorship with Active Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Prognostic Value of Clone Size in Paroxysmal Nocturnal Hemoglobinuria (PNH) for Thrombotic Events in Untreated Patients in the International PNH Registry 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical and Laboratory Diagnosis of Red Blood Cell Disorders: A Case-Based Algorithmic Approach 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all